Embolic Protection Devices Market by Product and Geography - Forecast and Analysis 2021-2025

Published: Aug 2021 Pages: 120 SKU: IRTNTR70853

The embolic protection devices market share is expected to increase by USD 470.39 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 10.01%.

This embolic protection devices market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers embolic protection devices market segmentation by product (distal filter devices and occlusion devices) and geography (North America, Europe, Asia, and ROW). The embolic protection devices market report also offers information on several market vendors, including Abbott Laboratories, Boston Scientific Corp., Cardinal Health Inc., Cardiovascular Systems, Inc., Contego Medical Inc., Edwards Lifesciences Corp., Innovative Cardiovascular Solutions LLC, Medtronic Plc, Silk Road Medical, Inc., and Venus Medtech (Hangzhou) Inc. among others.

What will the Embolic Protection Devices Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Embolic Protection Devices Market Size for the Forecast Period and Other Important Statistics

 

Embolic Protection Devices Market: Key Drivers, Trends, and Challenges

The incidence of cardiac diseases and adoption of PCI is notably driving the embolic protection devices market growth, although factors such as high cost of stenting may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the embolic protection devices industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Embolic Protection Devices Market Driver

One of the key factors driving growth in the embolic protection devices market is the incidence of cardiac diseases and adoption of PCI. The incidence of cardiac diseases is on the rise worldwide. In 2018, the CDC estimated that these diseases caused about 655,000deaths in the US. The organization also estimates that coronary heart disease was the most common cardiac disease, causing 375,000 deaths in the US annually. For treating coronary heart disease, physicians perform coronary angioplasty and stenting, a part of PCI, for diagnosis. These procedures help confirm the severity of the disease, with the physician performing coronary stenting to treat the blocked arteries. The rise in the cases of cardiac disorders will increase the volume of treatment procedures that include disease diagnosis and cardiac surgeries. This will increase the number of percutaneous coronary intervention procedures, which will lead to the demand, sales, and use of embolic protection devices.

Key Embolic Protection Devices Market Trend

The market expansion in emerging economies is another factor supporting the embolic protection devices market share growth. Emerging economies such as India, China, and South Africa drive the growth of the global embolic protection devices market. Factors such as the increasing incidence of various chronic diseases, rising income levels of people, growing awareness among people about the importance of healthcare, increasing investments in the private healthcare sector, and government initiatives for the development of the healthcare sector in rural areas provide significant market growth in these countries. Several players, including Boston Scientific, Terumo, Stryker, and Medtronic, are increasingly focusing on exploring the growth opportunities in emerging economies. Therefore, they are increasing their R&D investments and expanding their presence in emerging countries by building and expanding their manufacturing sites. Furthermore, key vendors are expanding their manufacturing facilities in emerging markets due to the availability of low-cost labor and the presence of a vast patient population. The huge potential in emerging economies is likely to contribute to the market growth.

Key Embolic Protection Devices Market Challenge

The high cost of stenting will be a major challenge for the embolic protection devices market during the forecast period. The demand for and use of embolic protection devices is low in many countries due to the high cost of stenting. The overall cost associated with stenting varies among hospitals based on the stent procedure, patient care, and hospital stay. The overall cost associated with stenting can be $12,000-$38,000, with the average price of the stents being $2,000-$4,500. The price of stents may further increase depending on the type of advanced technology used. These devices do not have a proper reimbursement, which restricts people from undergoing stenting, as they need to pay out of pocket for the overall expenses. This high cost of devices leads people to opt for alternatives such as therapeutic drugs for treating embolism.

This embolic protection devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

Technavio categories the global embolic protection devices market as a global healthcare equipment market. part of the Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the embolic protection devices market during the forecast period.

Who are the Major Embolic Protection Devices Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Cardiovascular Systems, Inc.
  • Contego Medical Inc.
  • Edwards Lifesciences Corp.
  • Innovative Cardiovascular Solutions LLC
  • Medtronic Plc
  • Silk Road Medical, Inc.
  • Venus Medtech (Hangzhou) Inc.

 

This statistical study of the embolic protection devices market encompasses successful business strategies deployed by the key vendors. The embolic protection devices market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Abbott Laboratories -The company offers embolic protection device for both lower extremity and carotid arteries.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The embolic protection devices market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Embolic Protection Devices Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the embolic protection devices market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the healthcare equipment market includes the following core components:

  • Research and development
  • Inputs
  • Operations
  • Distribution
  • Marketing and sales
  • Post-sales and services
  • Industry Innovation

The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Embolic Protection Devices Market?

For more insights on the market share of various regions Request for a FREE sample now!

41% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for embolic protection devices in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.

CVDs are the leading cause of death in the region, the incidence of which is on the rise. This will facilitate the embolic protection devices market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In early 2020, the outbreak of COVID-19 in the region led to a halt in the operations of manufacturing facilities, regulatory approvals, and vascular treatments, which restricted the production and use of EPDs and negatively impacted the growth of the market in the region. However, the market is expected to grow in the coming years after the pandemic is brought under control. The outbreak, which claimed over 914,210 lives in the US as of June 23, 2021, has prompted vendors to come up with new business strategies, such as online promotional activities and training for doctors, to meet the high demand for EPDs. This will help the regional market to grow during the forecast period.

What are the Revenue-generating Product Segments in the Embolic Protection Devices Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The embolic protection devices market share growth by the distal filter devices segment will be significant during the forecast period. The increasing demand for the usage of distal filters for thrombectomy patients with the increasing incidence of the target population and increasing adoption rate for minimally invasive surgical procedures is expected to boost the market growth for distal filters devices.

This report provides an accurate prediction of the contribution of all the segments to the growth of the embolic protection devices market size and actionable market insights on post COVID-19 impact on each segment.

 

Embolic Protection Devices Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 10.01%

Market growth 2021-2025

$ 470.39 million

Market structure

Concentrated

YoY growth (%)

9.62

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 41%

Key consumer countries

US, China, Germany, France, and Canada

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Boston Scientific Corp., Cardinal Health Inc., Cardiovascular Systems, Inc., Contego Medical Inc., Edwards Lifesciences Corp., Innovative Cardiovascular Solutions LLC, Medtronic Plc, Silk Road Medical, Inc., and Venus Medtech (Hangzhou) Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Embolic Protection Devices Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive embolic protection devices market growth during the next five years
  • Precise estimation of the embolic protection devices market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the embolic protection devices industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of embolic protection devices market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

***1. Executive Summary                        

***2. Market Landscape                          

              **2.1 Market ecosystem            

                             *Exhibit 01:  Parent market

                             *Exhibit 02:  Market characteristics

              **2.2 Value chain analysis         

                             *Exhibit 03:  Value chain analysis: Healthcare equipment

                             *2.2.1 Research and development

                             *2.2.2 Inputs

                             *2.2.3 Operations

                             *2.2.4 Distribution

                             *2.2.5 Marketing and sales

                             *2.2.6 Post-sales and services

     *2.2.7 Industry innovations

***3. Market Sizing                     

              **3.1 Market definition

                             *Exhibit 04:  Offerings of vendors included in the market definition

              **3.2 Market segment analysis 

                             *Exhibit 05:  Market segments

              **3.3 Market size 2020 

              **3.4 Market outlook: Forecast for 2020 - 2025 

                             *Exhibit 06:  Global - Market size and forecast 2020 - 2025 ($ million)

                             *Exhibit 07:  Global market: Year-over-year growth 2020 - 2025 (%)

***4. Five Forces Analysis                        

              **4.1 Five Forces Summary       

                             *Exhibit 08:  Five forces analysis 2020 & 2025

              **4.2 Bargaining power of buyers          

                             *Exhibit 09:  Bargaining power of buyers

              **4.3 Bargaining power of suppliers      

                             *Exhibit 10: Bargaining power of suppliers

              **4.4 Threat of new entrants    

                             *Exhibit 11:  Threat of new entrants

              **4.5 Threat of substitutes        

                             *Exhibit 12: Threat of substitutes

              **4.6 Threat of rivalry  

                             *Exhibit 13: Threat of rivalry

              **4.7 Market condition

                             *Exhibit 14:  Market condition - Five forces 2020

***5. Market Segmentation by Product             

              **5.1 Market segments

                             *The segments covered in this chapter are:

  • *Distal filter devices
  • *Occlusion devices

                            *Exhibit 15:  Product - Market share 2021-2026 (%)

              **5.2 Comparison by Product    

                             *Exhibit 16:  Comparison by Product

              **5.3 Distal filter devices - Market size and forecast 2020-2025  

                             *Exhibit 17:  Distal filter devices - Market size and forecast 2020-2025 ($ million)

                             *Exhibit 18:  Distal filter devices - Year-over-year growth 2020-2025 (%)

              **5.4 Occlusion devices - Market size and forecast 2020-2025    

                             *Exhibit 19:  Occlusion devices - Market size and forecast 2020-2025 ($ million)

                             *Exhibit 20:  Occlusion devices - Year-over-year growth 2020-2025 (%)

              **5.5 Market opportunity by Product    

                             *Exhibit 21:  Market opportunity by Product

***6. Customer landscape                       

                             *Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria

              **6.1 Customer landscape         

                             *Exhibit 22:  Customer landscape

***7. Geographic Landscape                   

              **7.1 Geographic segmentation

                             *The regions covered in the report are:

  • *North America
  • *Europe
  • *Asia
  • *ROW

                             *Exhibit 23:  Market share by geography 2020-2025 (%)

              **7.2 Geographic comparison  

                             *Exhibit 24:  Geographic comparison

              **7.3 North America - Market size and forecast 2020-2025          

                             *Exhibit 25:  North America - Market size and forecast 2020-2025 ($ million)

                             *Exhibit 26:  North America - Year-over-year growth 2020-2025 (%)

              **7.4 Europe - Market size and forecast 2020-2025         

                             *Exhibit 27:  Europe - Market size and forecast 2020-2025 ($ million)

                             *Exhibit 28:  Europe - Year-over-year growth 2020-2025 (%)

              **7.5 Asia - Market size and forecast 2020-2025

                             *Exhibit 29:  Asia - Market size and forecast 2020-2025 ($ million)

                             *Exhibit 30:  Asia - Year-over-year growth 2020-2025 (%)

              **7.6 ROW - Market size and forecast 2020-2025            

                             *Exhibit 31:  ROW - Market size and forecast 2020-2025 ($ million)

                             *Exhibit 32:  ROW - Year-over-year growth 2020-2025 (%)

              **7.7 Key leading countries       

                             *Exhibit 33:  Key leading countries

              **7.9 Market opportunity by geography

                             *Exhibit 34:  Market opportunity by geography ($ million)

***8. Drivers, Challenges, and Trends                 

              **8.1 Market drivers     

                             *8.1.1 Incidence of cardiac diseases and adoption of PCI

                             *8.1.2 Outsourcing embolic protection devices research to CROs

                             *8.1.3 Availability of favorable reimbursement coverage

              **8.2 Market challenges             

                             *8.2.1 High cost of stenting

                             *8.2.2 Lack of product differentiation leading to marginal profits

                             *8.2.3 Complications associated with use of embolic protection devices

                             *Exhibit 35:  Impact of drivers and challenges

              **8.3 Market trends     

                             *8.3.1 Market expansion in emerging economies

                             *8.3.2 Emergence of digital cath-labs in hospitals

                             *8.3.3 Implementation of organic and inorganic strategies by market players

***9. Vendor Landscape                          

              **9.1 Overview

                             *Exhibit 36:  Vendor landscape

              **9.2 Landscape disruption       

                             *Exhibit 37:  Landscape disruption

                             *Exhibit 38:  Industry risks

***10. Vendor Analysis              

              **10.1 Vendors covered             

                             *Exhibit 39:  Vendors covered

              **10.2 Market positioning of vendors   

                             *Exhibit 40: Market positioning of vendors

              **10.3 Abbott Laboratories       

                             *Exhibit 41:  Abbott Laboratories - Overview

                             *Exhibit 42:  Abbott Laboratories - Business segments

                             *Exhibit 43:  Abbott Laboratories - Key offerings

                             *Exhibit 44:  Abbott Laboratories - Segment focus

              **10.4 Boston Scientific Corp.   

                             *Exhibit 45:  Boston Scientific Corp. - Overview

                             *Exhibit 46:  Boston Scientific Corp. - Business segments

                             *Exhibit 47:  Boston Scientific Corp. - Key offerings

                             *Exhibit 48:  Boston Scientific Corp. - Segment focus

              **10.5 Cardinal Health Inc.        

                             *Exhibit 49:  Cardinal Health Inc. - Overview

                             *Exhibit 50:  Cardinal Health Inc. - Business segments

                             *Exhibit 51:  Cardinal Health Inc. - Key offerings

                             *Exhibit 52:  Cardinal Health Inc. - Segment focus

              **10.6 Cardiovascular Systems, Inc.       

                             *Exhibit 53:  Cardiovascular Systems, Inc. - Overview

                             *Exhibit 54:  Cardiovascular Systems, Inc. - Business segments

                             *Exhibit 55:  Cardiovascular Systems, Inc. - Key offerings

                             *Exhibit 56:  Cardiovascular Systems, Inc. - Segment focus

              **10.7 Contego Medical Inc.     

                             *Exhibit 57:  Contego Medical Inc. - Overview

                             *Exhibit 58:  Contego Medical Inc. - Product and service

                             *Exhibit 59:  Contego Medical Inc. - Key offerings

              **10.8 Edwards Lifesciences Corp.         

                             *Exhibit 60:  Edwards Lifesciences Corp. - Overview

                             *Exhibit 61:  Edwards Lifesciences Corp. - Business segments

                             *Exhibit 62:  Edwards Lifesciences Corp. - Key offerings

                             *Exhibit 63:  Edwards Lifesciences Corp. - Segment focus

              **10.9 Innovative Cardiovascular Solutions LLC 

                             *Exhibit 64:  Innovative Cardiovascular Solutions LLC - Overview

                             *Exhibit 65:  Innovative Cardiovascular Solutions LLC - Product and service

                             *Exhibit 66:  Innovative Cardiovascular Solutions LLC - Key offerings

              **10.10 Medtronic Plc  

                             *Exhibit 67:  Medtronic Plc - Overview

                             *Exhibit 68:  Medtronic Plc - Business segments

                             *Exhibit 69:  Medtronic Plc - Key offerings

                             *Exhibit 70:  Medtronic Plc - Segment focus

              **10.11 Silk Road Medical, Inc. 

                             *Exhibit 71:  Silk Road Medical, Inc. - Overview

                             *Exhibit 72:  Silk Road Medical, Inc. - Product and service

                             *Exhibit 73:  Silk Road Medical, Inc. - Key offerings

              **10.12 Venus Medtech (Hangzhou) Inc.            

                             *Exhibit 74:  Venus Medtech (Hangzhou) Inc. - Overview

                             *Exhibit 75:  Venus Medtech (Hangzhou) Inc. - Product and service

                             *Exhibit 76:  Venus Medtech (Hangzhou) Inc. - Key offerings

***11. Appendix                          

              **11.1 Scope of the report        

                             *11.1.1 Market definition

                             *11.1.2 Objectives

                             *11.1.3 Notes and caveats

              **11.2 Currency conversion rates for US$           

                             *Exhibit 77:  Currency conversion rates for US$

              **11.3 Research Methodology  

                             *Exhibit 78:  Research Methodology

                             *Exhibit 79:  Validation techniques employed for market sizing

                             *Exhibit 80:  Information sources

              **11.4 List of abbreviations       

                             *Exhibit 81:  List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

embolic protection devices market

QUICK BUY

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis